All In MedTech

Company

Koru Medical Systems

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2022–$407K––
2021–$1.3M––

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.

The investor database is free with an account

For Koru Medical Systems we have 4 shareholders with 5% or more.

Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.

Latest FDA decisions

Search the Clearance Tracker

4 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT07189013 · 52 participants (planned) · Start Oct 15, 2025 · Primary completion Mar 2026

    Device: Mechanical infusion pump · For: Primary Immunodeficiencies (PID); Secondary Immunodeficiencies (SID)

    Sites: London, United Kingdom

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 237000
Jan 2421000
Feb 2415001
Mar 2411100
Apr 2410100
May 2411100
Jun 249100
Jul 2410000
Aug 2412000
Sep 2412200
Oct 2418200
Nov 2420100
Dec 248101
Jan 2523100
Feb 2510000
Mar 2523100
Apr 253100
May 259000
Jun 2521000
Jul 254000
Aug 256000
Sep 2531102
Oct 2550001
Nov 2511000
Dec 2515100
Jan 2619000
Feb 2624000
Mar 2621000
Apr 2624000
May 2611000
Jun 2625000
Jul 269009
Aug 2630020
Sep 266000
Oct 262000
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

The full in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recalls under this name in FDA's data.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.